Fabrice Bonnet, André J Scheen. Editorial. SGLT-2 receptor inhibitors: An opportunity to revise our therapeutic strategy for type 2 diabetes?.
Diabetes and Metabolism, Elsevier Masson, 2014, 40 (6 Suppl 1), pp.S1-3.
⟨10.1016/S1262-3636(14)72688-6⟩.
⟨hal-01134740⟩